CMS proposal limits coverage of drug to help diagnose Alzheimer’s.
By: chris.placitella @ Jul 07, 2013
On Wednesday, the Centers for Medicare & Medicaid Services proposed that “Medicare will pay the costs of brain imaging that uses a Eli Lilly & Co. drug to help diagnose Alzheimer’s disease only for patients participating in approved clinical studies,” Bloomberg News (7/4, Lopatto) reported. According to regulators, “there isn’t enough evidence to show […]
Brought to you by: